摘要
目的探究血栓通注射液在急性ST段抬高型心肌梗死治疗中的应用效果。方法选取我院2012年3月~2015年3月收治的120例急性ST段抬高型心肌梗死患者作为研究对象,随机分成对照组（60例）和观察组（60例）。对照组予以常规治疗,观察组在对照组常规治疗的基础上,增加血栓通注射液治疗。结果观察组的血清学指标、超声心动图检测指标及心脏不良反应发生率均显著优于对照组（P〈0.05）。结论血栓通注射液在急性ST段抬高型心肌梗死的治疗中具有良好的应用效果。
Objective To investigate the application of Xueshuantong injection in the treatment of acute STelevation myocardial infarction. Methods A total of 120 patients with acute ST-elevation myocardial infarction who were admitted to our hospital from March 2012 to March 2015 were enrolled as study subjects and randomly divided into control group and observation group, with 60 patients in each group. The patients in the control group were given conventional treatment, and those in the observation group were given Xueshuantong injection in addition to the conventional treatment. Results Compared with the control group, the observation group had better serological markers,better echocardiographic results, and a lower incidence rate of adverse cardiac events（P〈0.05）. Conclusion Xueshuantong injection has a good clinical effect in the treatment of acute ST-elevation myocardial infarction.
出处
《心血管病防治知识（学术版）》
2016年第3期48-49,共2页
Prevention and Treatment of Cardiovascular Disease
